Developing protein therapeutics for cancers and autoimmune diseases.
Industry: Health Care
First Day Return: +0.6%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 07/26/2013 |
Offer Price | $13.00 |
Price Range $12.00 - $14.00 | |
Offer Shares (mm) | 4.8 |
Deal Size ($mm) | $62 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 09/17/2013 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $62 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | South San Francisco, CA, United States |
Founded | 2001 |
Employees at IPO | 108 |
Website www.fiveprime.com |